BARCLAYS PLC (BARC) — Investment Research Note
Executive summary
Barclays is a UK-headquartered universal bank operating five divisions — UK retail, UK Corporate, Private Bank & Wealth, Investment Bank (c.56% of RWAs) and US Consumer Bank — with a materially diversified income mix (H126 income £16.5bn, +11% YoY). The trajectory across the covered period is a clear re-rating from a sub-10% RoTE bank in 2021 to a 14.8% H126 RoTE with upgraded 2026 (RoTE >12%, income c.£31.5bn) and 2028 (RoTE >14%, >£15bn 2026-2028 capital returns) targets. The single most important point for valuation today is that Barclays now generates double-digit returns across every division with CET1 at 14.3% (top of the 13-14% range), yet still trades at only c.1.02x TNAV — the strategy delivery is visible in the numbers but has not yet been fully re-rated by the market.
Fair value estimate
- Methodology: blended price-to-TNAV and forward P/E for UK banks. H126 TNAV/share 423p. Annualising H126 EPS of 30.7p gives a run-rate of c.61p; applying normalised 2026/27 EPS of c.60-65p.
- Low: 1.1x TNAV / 8x fwd EPS → ~465p (implied mcap c.£62bn)
- High: 1.35x TNAV / 10x fwd EPS → ~570p (implied mcap c.£76bn)
- Mid: ~520p / c.£69bn mcap vs current £57.7bn
- Upside: c.20% to midpoint, c.32% to high, c.7% to low. 2026-07 half-year; market data 2026-10-16
Rationale: UK banks with sustainable 12-14% RoTE and progressive capital return typically trade 1.1-1.4x TNAV. Barclays' delivered RoTE now runs well above the 12% 2026 target with cost:income at 55% (vs low-50s 2028 target), supporting the upper half of that range.
Sector context
Confirmed classification: Financials / Banks, specifically a universal bank with major investment-banking exposure. Quality is in line with large UK peers (NatWest, Lloyds) on capital and asset quality, higher growth given the investment bank and USCB, and higher cyclicality than pure UK-focused peers. Listed peers: Lloyds Banking Group, NatWest Group, HSBC (though HSBC's Asia tilt differs materially). Barclays trades at a modest discount to Lloyds/NatWest on P/TNAV despite higher group RoTE — explained by the IB's more volatile earnings profile.
Investment thesis
- Delivery against 2024-2026 plan is tangible. H126 Group RoTE 14.8%, all five divisions double-digit, EPS up 24% YoY to 30.7p, income guidance for 2026 raised to c.£31.5bn (from c.£31bn), UK NII to >£13.7bn. The 2028 target of >14% RoTE and >£15bn capital returns 2026-28 is credible given the trajectory. 2026-07 half-year
- Capital return story remains the core shareholder-friendly story. £2.3bn total distributions announced for H126 alone (£1bn buyback + c.£0.8bn dividend + prior £500m) — 61% YoY increase. Share count fell to 13.5bn (-5% YoY). CET1 at 14.3% leaves comfortable headroom even after announced returns. 2026-07 half-year
- Structural hedge tailwind continues to compound. Gross hedge contributions were £3,456m in H126 vs £2,778m H125, with hedge notional of £240bn and 3.5-year average duration — this provides multi-year NII visibility independent of near-term rate moves. 2026-07 half-year
Key risks
- US Consumer Bank credit normalisation and regulatory capital. USCB LLR of 575bps H126 and 90-day arrears 1.6%; CET1 benefit from AA portfolio sale is one-off and £11bn RWA uplift expected H2 2027 from USCB moving to IRB. 2026-07 half-year
- Motor finance redress and litigation tail. Provision £430m at H126; FCA scheme suspended pending Upper Tribunal challenges, with Barclays strongly disagreeing with aspects of the FCA rules — outcome and quantum remain uncertain. 2026-07 half-year
- IB income volatility and Basel 3.1 RWA inflation. Investment Bank is 56% of Group RWAs; c.£8-15bn RWAs expected from Basel 3.1 from 1 January 2027. Market share gains in Equities and advisory are good but Q126 included a £228m single-name impairment showing exposure to idiosyncratic credit events. 2026-07 half-year
Operating leverage
Barclays' operating leverage is moderate — characteristic of a bank, not a scaleable platform. H126 cost:income was 55% improving from 58% H125, with c.£350m of efficiency savings delivered in H126 against a target of >£2bn gross efficiency savings 2026-2028. The structural hedge provides a form of operating leverage: incremental deposits re-invested at prevailing swap rates flow through at near-100% margin, which is why Barclays UK NIM expanded to 3.70% H126 from 3.55% H125 despite retail deposit pressure. However, incremental revenue growth is tied to incremental RWAs and compensation (performance costs rose with higher IB income), so a 10-20% revenue surprise would not deliver anywhere near a 2x profit surprise — more likely 25-40% uplift to PBT given the ~55% cost base is variable (performance comp, impairment). The business is capital-light at group level but RWA-constrained, which caps the operating leverage story relative to pure software/platform businesses. 2026-07 half-year
Value-trap signals
None identified. Income is growing, dividends and buybacks are rising, management guidance has been upgraded, delinquencies are stable, CET1 is strong, and the strategic plan is being executed. The relative valuation discount versus NatWest/Lloyds is explained by IB-income volatility rather than a structural impairment.
Earnings vs. expectations
- Q226 vs guidance: income beat drove 2026 income guidance upgrade (c.£31bn → c.£31.5bn) and UK NII upgrade (>£13.5bn → >£13.7bn). RoTE 16.1% in Q226 well above the >12% full-year target. Beat. 2026-07 half-year
- H126 vs H125: income +11%, PBT +17%, EPS +24% (30.7p vs 24.7p). RoTE 14.8% vs 13.2%. All divisions double-digit RoTE. Beat. 2026-07 half-year
- FY25 (prior year context): 2025 RoTE target of c.11% was delivered; capital returns rose; plan execution continued on track. Met-to-beat.
Pattern: three consecutive periods of beats and guidance upgrades on NII and RoTE, with management repeatedly raising targets rather than cutting them. This reflects strong structural hedge roll-on and better-than-expected UK deposit dynamics.
Conviction
4 — high. Anchors: (1) half-year disclosure is detailed and clean — RoTE and RWA walks are reconcilable; (2) multiple valuation approaches (P/TNAV and fwd P/E) converge on a 500-530p mid; (3) consistent delivery against a public 3-year plan reduces estimate dispersion. Caveats: (a) IB income carries higher volatility than retail banking, which widens the plausible RoTE range by 2-3 points; (b) regulatory outcomes (motor finance, Basel 3.1 recalibration, USCB IRB implementation) could move RWAs and provisions by £5bn-£20bn.